David C H Harris Selected Research

Cysts

1/2021	Up-Regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease.
1/2018	Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).
12/2014	Pyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David C H Harris Research Topics

Disease

17	Fibrosis (Cirrhosis) 01/2021 - 10/2003
16	Chronic Renal Insufficiency 05/2021 - 04/2005
15	Inflammation (Inflammations) 01/2022 - 08/2001
11	Proteinuria 01/2022 - 08/2001
7	Renal Insufficiency (Renal Failure) 05/2021 - 03/2020
7	Kidney Diseases (Kidney Disease) 05/2021 - 08/2012
6	Nephrosis 10/2013 - 04/2005
6	Atrophy 05/2012 - 08/2001
5	Sclerosis 01/2022 - 10/2003
4	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2019 - 06/2008
4	Necrosis 05/2015 - 01/2005
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 01/2006
3	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2021 - 01/2018
3	Cysts 01/2021 - 12/2014
3	Chronic Kidney Failure (Chronic Renal Failure) 03/2020 - 07/2009
3	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2019 - 01/2013
2	Glomerulonephritis 01/2022 - 01/2019
2	Noncommunicable Diseases 05/2021 - 03/2020
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2011
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2012
2	Reperfusion Injury 01/2018 - 01/2018
2	Atherosclerosis 01/2018 - 01/2012
2	Infections 01/2016 - 05/2015
2	Nephritis 04/2015 - 01/2013
2	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 02/2006
2	Neoplasms (Cancer) 01/2013 - 01/2011
1	Cystic Kidney Diseases (Cystic Kidney Disease) 01/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Disease Progression 11/2020
1	Acute Kidney Injury (Acute Renal Failure) 03/2020
1	Sjogren's Syndrome (Sjogren Syndrome) 04/2017
1	Ischemia 01/2016
1	Body Weight (Weight, Body) 12/2014
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 12/2014
1	Heart Diseases (Heart Disease) 02/2013
1	Virus Diseases (Viral Diseases) 01/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2011
1	Glycosuria 10/2009
1	Hypertension (High Blood Pressure) 10/2009

Drug/Important Bio-Agent (IBA)

17	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 08/2001
12	CreatinineIBA 06/2012 - 08/2001
6	CytokinesIBA 01/2022 - 06/2010
6	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2005
4	AntigensIBA 01/2019 - 01/2013
4	DNA VaccinesIBA 01/2019 - 02/2006
4	ChemokinesIBA 01/2018 - 06/2005
3	Biological ProductsIBA 01/2021 - 07/2004
3	CateninsIBA 01/2018 - 01/2011
2	Interleukin-33IBA 01/2022 - 01/2018
2	VaccinesIBA 01/2019 - 01/2018
2	Chemokine CX3CL1IBA 01/2018 - 01/2012
2	Matrix Metalloproteinases (MMPs)IBA 05/2017 - 03/2010
2	Cadherins (E-Cadherin)IBA 01/2016 - 01/2011
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2016 - 04/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2015 - 03/2010
2	AutoantibodiesIBA 04/2015 - 02/2006
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2013 - 01/2012
2	Chemotactic FactorsIBA 05/2013 - 04/2009
2	NF-kappa B (NF-kB)IBA 01/2005 - 08/2001
2	Malondialdehyde (Propanedial)IBA 03/2002 - 08/2001
1	B-Cell Activating FactorIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	NADP (NADPH)IBA 01/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2021
1	Histones (Histone)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Dietary SodiumIBA 11/2020
1	SodiumIBA 11/2020
1	SaltsIBA 11/2020
1	Dialysis SolutionsIBA 01/2018
1	ICG 001IBA 01/2018
1	LipidsIBA 01/2018
1	A-Form DNA (A-DNA)IBA 01/2018
1	Arginine Vasopressin (Argipressin)IBA 01/2018
1	integrin-linked kinaseIBA 01/2016
1	IntegrinsIBA 01/2016
1	Pathogen-Associated Molecular Pattern MoleculesIBA 05/2015
1	renal tubular antigenIBA 04/2015
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 04/2015
1	prolinedithiocarbamate (PDTC)IBA 12/2014
1	pyrrolidine dithiocarbamic acidIBA 12/2014
1	Therapeutic UsesIBA 07/2013
1	Inflammation MediatorsIBA 05/2013
1	OsteopontinIBA 04/2013
1	AutoantigensIBA 01/2013
1	LipopolysaccharidesIBA 05/2012
1	Chemokine ReceptorsIBA 01/2012
1	LigandsIBA 01/2012
1	Streptozocin (Streptozotocin)FDA Link 01/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2010
1	Blood Glucose (Blood Sugar)IBA 10/2009

Therapy/Procedure

7	Renal Replacement Therapy (Therapies, Renal Replacement) 05/2021 - 04/2005
7	Therapeutics 03/2020 - 01/2006
6	Kidney Transplantation 05/2021 - 01/2016
3	Transplantation 05/2021 - 01/2016
3	Intraperitoneal Injections 12/2014 - 10/2003
2	Peritoneal Dialysis 05/2021 - 06/2010
1	Immunotherapy 01/2018